Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2024)
Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial.
PARISH S. et al, (2023), European Heart Journal
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.
Harper C. et al, (2023), Heart, 109, 1467 - 1472
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet, 401, 1499 - 1507
Data provenance and integrity of health-care systems data for clinical trials.
Murray ML. et al, (2022), Lancet Digit Health, 4, e567 - e568
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
RECOVERY Collaborative Group None. et al, (2022)
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2022)
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Keng MJ. et al, (2021), Value in Health
What is the association of COVID-19 with heart attacks and strokes?
Mafham M. and Baigent C., (2021), Lancet, 398, 561 - 563
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113
Making trials part of good clinical care: lessons from the RECOVERY trial.
Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645